Carl Fredrik W.
- Country
- Sweden
- Department
- Onkologimottagning medicinsk behandling
Research Overview
- Adjuvant mitotane vs. mitotane with cisplatin/etoposide after primary surgical resection of localised adrenocortical carcinoma with high risk of recurrence (ADIUVO-2 Trial): A pragmatic, randomised, low-intervention phase III, clinical trial with an observational arm.
- Phase III Trial of BI 764532 Plus Carboplatin and Etoposide Versus Carboplatin and Etoposide in Previously Untreated DLL3-Positive Advanced Extrapulmonary Neuroendocrine Carcinoma
- Phase III Randomized Study of 177Lu-PSMA-617 Versus Androgen Receptor-Directed Therapy in Taxane-Naïve Metastatic Castration-Resistant Prostate Cancer
Data & Insights
Has run more than one trial at 11 of 113 partner sites.
Specializations
Endocrine Oncology
The investigator specializes in the treatment of adrenocortical carcinoma, focusing on advanced therapeutic approaches for high-risk cases following surgical intervention. Their research encompasses the evaluation of adjuvant treatment strategies, particularly exploring the efficacy of mitotane-based therapies.
- Adrenal Cancer Management
- Post-surgical Treatment Optimization
- Endocrine Tumor Therapy
Their expertise extends to integrating various treatment modalities for optimal patient outcomes in endocrine oncology.
Urological Oncology
The investigator demonstrates particular expertise in treating metastatic castration-resistant prostate cancer, with a focus on innovative radioligand therapies. Their work involves evaluating advanced treatment options for patients with PSMA-positive prostate cancer.
- Prostate Cancer Treatment
- Targeted Radiotherapy
- Advanced Disease Management
The investigator's work encompasses novel therapeutic approaches in progressive prostate cancer cases.
Precision Medicine
The investigator's research reflects expertise in targeted therapeutic approaches, incorporating both conventional and innovative treatment modalities. Their work demonstrates proficiency in personalized treatment strategies for complex oncological conditions.
- Molecular Targeting
- Combination Therapy
- Treatment Optimization
Their approach integrates multiple therapeutic modalities for personalized cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.